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Abstract
Discoveries of new biomarkers for frequently occurring diseases are of special
importance in today’s medicine. While fully developed type II diabetes (T2D)
can be detected easily, the early identification of high risk individuals is an area
of interest in T2D, too. Metagenomic analysis of the human bacterial flora has
shown subtle changes in diabetic patients, but no specific microbes are known
to cause or promote the disease. Moderate changes were also detected in the
microbial gene composition of the metagenomes of diabetic patients, but again,
no specific gene was found that is present in disease-related and missing in
healthy metagenome. However, these fine differences in microbial taxon- and
gene composition are difficult to apply as quantitative biomarkers for diagnosing
or predicting type II diabetes. In the present work we report some nucleotide
9-mers with significantly differing frequencies in diabetic and healthy intestinal
flora. To our knowledge, it is the first time such short DNA fragments have been
associated with T2D. The automated, quantitative analysis of the frequencies of
short nucleotide sequences seems to be more feasible than accurate phylogenetic
and functional analysis, and thus it might be a promising direction of diagnostic
research.
Keywords: Type II diabetes, metagenome, biomarkers, G-C content, oligomers,
short nucleotide sequences, tetranucleotides.
1. Introduction
Metagenomics [1] is rapidly gaining importance in clinical research [2, 3, 4, 5, 6,
7, 8, 9], environmental studies [10, 11, 12] and biotechnology [13, 14, 15]. Numer-
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ous complex and reliable methods have been published for the phylogenetic iden-
tification of non-cloned short DNA reads from environmental or clinical samples,
for example, the similarity-based methods MEGAN [16, 17, 18] and MG-RAST
[19, 20], the marker-gene identifying phylogenetic analyzer AMPHORA [21] and
its more user-friendly versions, AMPHORA2 [22] and AmphoraNet [23, 24].
These methods use multi-phase, complex approaches to retrieve phylogenetic
information from the short read datasets, applying reference database operations
in the process.
Surprisingly, it was shown that simple frequency counting of nucleotides or short
nucleotide sequences in the metagenomic samples may also imply phylogenetic
information.
It has been widely known for a long time that genomic AT/GC ratio is dis-
tributed in a wide range in bacterial species, and can be characteristic to some
of them [25, 26, 27]. The ratio is shown to be influenced by numerous environ-
mental and metabolic factors [28] and also carries phylogenetic information.
The article [29] reports differences in di- and tetranucleotide frequencies among
numerous bacterial species, and examines the possible application of these sig-
natures in molecular phylogeny.
Tetranucleotide sequence frequencies were applied in supervised and unsuper-
vised phylogenetic classification, or “binning” in [30].
The work [31] applies conserved gene fragments, each encoding several dozens of
amino acids, identified from the Pfam database [32]. The fragments are called
“environmental gene tags”, and are used successfully for phylogenetic binning in
[31].
The study of [3] investigated the differences in gut metagenomes of diabetic
and healthy subjects. The metagenomes were de novo assembled, and the bac-
terial genes were mapped to a metagenomic gene catalog. Genes related to
oxidative stress response were found more abundant in the samples originating
from diabetic subjects. Additionally, moderate changes in intestinal bacterial
composition were detected, but no specific microbes were associated with the
metagenomes of the type II diabetes (T2D) patients.
After a very complex selection and filtering process, genome-specific nucleotide
markers of length 50 were identified in [33]. The markers were applied for
strain/species identification, and also as markers for microbial species that might
play a role in T2D and obesity in the data set of [3].
Here we describe a very simple and straightforward approach for finding short
nucleotide sequences whose frequencies significantly differ in T2D and healthy
metagenomes of the dataset of [3]. We identify several nucleotide 9-mers that
may serve as quantitative biomarkers of the pre-diabetic state in the future. To
our knowledge, such short sequences have never been found to characterize T2D
or any other disease.
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We need to clarify that we do not state that the identified 9-mers will generally
be applicable as biomarkers for diabetes for all human populations. We be-
lieve that “enterotype-specific” [34] quantitative biomarkers could be found for
each enterotypes by exhaustive searches described in the Methods section, and
those enterotype-specific biomarkers could serve as predictors of type 2 diabetes
mellitus.
2. Discussion and Results
Our results are summarized on Table 1 and on Figure 1. Table 1 contains 20
7-, 8- and 9-mers of the highest statistical significance, distinguishing between
the diabetic and non-diabetic metagenomes of the study [3].
Table 1 was prepared without considering complementarities between the short
nucleotide sequences. Therefore, the complements found with very close fre-
quencies and statistical parameters independently verify our results. It is easy
to recognize in Table 1 that TGTGGTA and TACCACA are exact comple-
ments. The complement of TCCACAT, ATGTGGA, is almost the prefix of
ATGTGGTAC. The complement of TGTGGTACT (line 3) is again the exact
complement of AGTACCACA (line 6), just to mention some of the complemen-
tarities in the table.
Figure 1 gives the empirical cumulative distribution functions of the frequency
of 9-mer TGTGGTGTA in the diabetic and in the non-diabetic samples. The
difference between the expected values (means) of the two distribution is obvious
on the figure and is quantified statistically in Table 1.
We also searched for short nucleotide sequences characterizing lean/obese and
male/female individuals in the dataset of [3]. Only one short sequence passed
the statistical significance bound in the lean/obese search, and none in the
male/female search (c.f. Table S1 and S2 and Figure S1 in the Appendix).
The source of the bias in short nucleotide sequence frequencies is most proba-
bly due to the difference in the gene- and species composition of diabetic and
healthy metagenomes, found in [3, 33]. These frequencies could be measured
and evaluated more easily than the much more involved characteristics found in
[3, 33].
3. Materials and Methods
Our data source was the set of metagenomes of 345 Chinese subjects, col-
lected by Qin et al. [3] and deposited in the Sequence Read Archive
(http://www.ncbi.nlm.nih.gov/sra) under accession numbers SRA045646 (145
subjects) and SRA050230 (225 subjects). The assembled data was downloaded
from the GigaScience database, GigaDB at http://dx.doi.org/10.5524/100036.
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We considered all the possible DNA sequences of length at most 9 (this means
over 300,000 possible sequences). For each sequence, we counted the number
of exact matches in each raw metagenome. Our aim was to determine whether
there are any short DNA fragments whose frequencies differ for diabetic/non-
diabetic, lean/obese or female/male individuals.
We first defined the frequency of a short DNA fragment for a given metagenome
as the number of occurrences (exact matches), divided by the total size, mea-
sured in base-pairs (bp), of the metagenome. Additionally – to account for minor
mutations – we also included those sequences in the counting process that dif-
fered by only one nucleotide, but these were considered with half a weight. So,
for example, the final frequency of the sequence AAA included not only how
many times the sequence AAA occurs in a specific metagenome, but also how
many times AAG, CAA, ATA, ... occur in that metagenome, except that the
number of occurrences for these related DNA fragments was divided by two.
Let ℓM denote the length in base-pairs (bp) of a metagenome M . Let d(s, t)
be the number of mismatches between the two sequences of same length, s
and t (also called the Hamming distance). Let kM (s) denote the number of
exact matches of sequence s in metagenome M . Then fM (s) (the frequency of
sequence s with respect to metagenome M) is defined by the formula
fM (s) =
1
ℓM

kM (s) + 1
2
∑
d(s,t)=1
kM (t)

 .
This approach (counting some non-exact matches as well, but with the half
the weight) yielded statistically better results when compared to the original,
stricter counting process, which only allowed exact matches.
We developed C++ programs for counting the fragments and analyzing the
results. Several partitions on the set of subjects were analyzed, by dividing
them into two groups by different attributes: diabetic/non-diabetic, lean/obese
and female/male. Our aim was to look for short DNA sequences whose mean
frequency differs for the two groups.
To achieve this, first we calculated fM (s) for each raw/assembled metagenome
M and each short DNA sequence s of length ℓs ≤ 9. Then, for each s we
calculated a p-value using Welch’s t-test, which showed whether the frequency
s is the same in the two groups (i.e., p is large) or differs significantly (i.e.,
p ≤ 0.05).
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Figure 1: Empirical cumulative distribution function of the frequency of 9-
mer TGTGGTGTA (solid: diabetic, dashed: non-diabetic). For every value
x the curves demonstrate the diabetic (solid line) and non-diabetic (dashed
line) fraction of metagenomes with TGTGGTGTA frequency of at most x. For
example, for x = 0.000045, 70% of the diabetic samples have the TGTGGTGTA
frequency less than x, while only 38% of the non-diabetic samples have that
frequency less than x. Further empirical cumulative distribution functions are
given in the Appendix.
Since this was done for each short DNA fragment, the number of total statistical
tests done for a given division of subjects was equal to the number of possible
s DNA sequences of length at most 9. As this is more than 300,000, there was
a high probability that one of the tests would yield a very low p-value but the
large measured difference of means would be in fact due to mere chance.
Therefore we utilized a two-step hypothesis testing procedure. First we com-
puted the p-values for Study 1 (with 145 subjects, SRA accession number
SRA045646) only, which now became our training set. Then we sorted the pos-
sible s sequence candidates by p-value ascending, and chose those 20 sequences
which had the lowest p-value. These were those sequences which showed promise
that their frequency might differ significantly between diabetic/non-diabetic,
lean/obese and female/male individuals, depending our current partitioning of
the subjects. Then we tested these selected sequences (and corresponding sta-
tistical hypotheses) on the holdout set, which was the collection of metagenomes
from Study 2 (SRA accession number SRA050230, 225 subjects). On this set
we performed only those 20 tests which qualified in the first round, which again
yielded a second p-value for each of the 20 DNA sequences.
Fragment Diabetic Non-diabetic p (training set) p (holdout set) p (corrected)
TGTGGTGTA 4.475e-05 4.713e-05 7.8e-09 0.000296 0.005928
TGTGCTATC 4.346e-05 4.549e-05 1.871e-08 0.001764 0.033518
TGTGGTACT 4.009e-05 4.164e-05 9.508e-10 0.001929 0.034726
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TGTGGTA 0.0006214 0.0006428 1.397e-08 0.001937 0.032922
TGTGGTACA 4.672e-05 4.875e-05 2.973e-08 0.002098 0.033564
AGTACCACA 4.096e-05 4.242e-05 2.152e-08 0.002246 0.033686
CCATCTGT 0.0002318 0.0002424 2.138e-08 0.003092 0.043284
TGCCACATA 5.811e-05 6.126e-05 6.417e-09 0.004678 0.060818
TGTGGTATG 4.813e-05 5.04e-05 9.19e-09 0.004925 0.059099
TACCACA 0.0006332 0.0006531 3.377e-08 0.004999 0.054987
TGTGGAGAT 6.544e-05 6.788e-05 1.523e-08 0.008901 0.089010
TGTGGTATC 5.035e-05 5.248e-05 1.492e-08 0.011902 0.107118
ATGGTCTGT 5.845e-05 6.071e-05 1.291e-08 0.012383 0.099068
GTACCACAT 4.179e-05 4.311e-05 1.055e-08 0.012814 0.089698
CCACATACT 5.127e-05 5.348e-05 2.436e-08 0.014294 0.085764
ATGTGGTAC 4.135e-05 4.266e-05 9.495e-09 0.024340 0.121702
TCTCCACAT 6.968e-05 7.255e-05 1.582e-08 0.074780 0.299121
ATCTCCACA 6.615e-05 6.84e-05 5.427e-09 0.078516 0.235547
CTCCACATA 5.578e-05 5.753e-05 2.018e-08 0.257111 0.514221
TCCACAT 0.0008132 0.0008294 1.919e-08 0.266428 0.266428
Table 1: Frequencies of 7-, 8- and 9-mers in diabetic vs. non-diabetic samples
with the highest significance (training set: Study 1, holdout set: Study 2). The
training set p-values are highlighted for the statistically significant multimers
(p < 0.05 with Holm-Bonferroni correction). It is easy to recognize that TGTG-
GTA and TACCACA are exact complements. The complement of TCCACAT,
ATGTGGA, is almost the prefix of ATGTGGTAC. 9-mer TGTGGTACT (line
3) is the exact complement of AGTACCACA (line 6). One can find further
complementarities in the table. These independently found complements with
very close frequencies and p-values strengthen our findings. More tables (for
lean-obese and female-male distributions) are given in the Appendix.
Then the Holm-Bonferroni correction was used to determine which of the se-
quences had a significantly different frequency among the two groups. This
correction algorithm effectively calculates an upper bound for a p-value which
takes the fact that we performed multiple (i.e., 20) statistical tests into account.
Since the frequencies in the second study are independent from those in the first
study, the first one is indeed a suitable training set for the model, and we can
safely ignore that we performed over 300,000 statistical tests on the first study,
since we use only the tests on the holdout set to make predictions.
We have applied the raw, unassembled metagenomes from Study 1 and Study
2 to look for short marker sequences of diabetes.
Unfortunately, there was not enough information available to us to determine
which subjects of Study 2 are lean/obese or female/male. Thus we had to use
the available assembled metagenomes in Study 1 to look for marker fragments
for sex and obesity. We partitioned the assembled metagenomes of the first
study into two“random”groups: one of the groups consisted of those individuals
with an odd subject ID, and the other group contained those with an even ID.
One of these was the training set and the other became the holdout set, i.e.
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they took the role of Study 1 and Study 2 for the lean/obese and female/male
classifications (Tables S1 and S2 in the Appendix).
One sequence passed the significance threshold for the lean/obese division, and
none of the short sequences had a significant difference of frequency between
the two sexes.
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5. Appendix
Fragment Lean Obese p (training set) p (holdout set) p (corrected)
CTCGTGACA 2.002e-05 1.901e-05 0.002091 0.001443 0.028859
CTCGATTGT 2.848e-05 2.727e-05 0.002945 0.004539 0.086232
TGTCGACTG 2.459e-05 2.3e-05 0.0009184 0.005781 0.104062
ACACTCGAG 1.126e-05 1.025e-05 0.001831 0.006911 0.117490
CTCGAGTGT 1.127e-05 1.025e-05 0.002036 0.012364 0.197821
TGTGACTCG 1.354e-05 1.291e-05 0.002158 0.014499 0.217484
ATGTGAGGC 2.35e-05 2.255e-05 0.001805 0.016175 0.226446
GTGCCTCTC 2.382e-05 2.26e-05 0.002931 0.019559 0.254270
GGCTCACTC 1.817e-05 1.722e-05 0.003306 0.031810 0.381714
CGAGTGAGA 1.858e-05 1.786e-05 0.003293 0.036067 0.396741
CACTCGAGG 1.205e-05 1.087e-05 0.003403 0.061201 0.612006
GAGTGAGCT 2.149e-05 2.059e-05 0.003223 0.062982 0.566836
CTCGACTGT 2.062e-05 1.954e-05 0.003178 0.071181 0.569449
CTGTCGTGT 2.723e-05 2.629e-05 0.00301 0.077670 0.543687
TGTGGTTGA 5.722e-05 5.518e-05 0.002553 0.121549 0.729294
CACTCGTGG 1.633e-05 1.524e-05 0.002677 0.130222 0.651109
TCACCATGT 4.975e-05 4.83e-05 0.003499 0.283407 1.133628
TCTAGCCTG 1.786e-05 1.729e-05 0.003271 0.561284 1.683851
AACAGCCAC 5.328e-05 5.22e-05 0.002606 0.697098 1.394196
CTAGCTGTC 2.083e-05 2.036e-05 0.001805 0.882905 0.882905
Table S1: Frequencies of ninemers of in lean vs. obese samples with the highest
significance (training and holdout sets: two halves of Study 1). The boldface
number in column 4 denotes the significant difference by Holm-Bonferroni cor-
rections, shown in the last column.
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Fragment Male Female p (training set) p (holdout set) p (corrected)
TAGTACTGG 2.748e-05 2.854e-05 0.006019 0.174548 3.490951
TTCATAGGG 3.385e-05 3.479e-05 0.0005157 0.305204 5.798868
AGTCTCAGG 2.314e-05 2.229e-05 0.007333 0.353644 6.365594
GATGTGTCT 3.878e-05 3.841e-05 0.006985 0.452399 7.690776
GTCTCACAC 1.635e-05 1.594e-05 0.00236 0.495140 7.922244
CTCAGTCT 0.0001047 0.0001014 0.006424 0.512597 7.688961
CATGTAACC 2.969e-05 2.932e-05 0.001608 0.515833 7.221663
GCTTCAGAC 4.097e-05 3.98e-05 0.006813 0.546829 7.108781
CTCTAACAC 2.147e-05 2.098e-05 0.006313 0.578498 6.941978
ACAGACTCA 3.893e-05 3.82e-05 0.007392 0.582096 6.403058
GGTCAATTC 4.215e-05 4.266e-05 0.006413 0.595760 5.957600
TGTGAGTCT 2.247e-05 2.204e-05 0.007573 0.618236 5.564123
CAGACTCAT 4.513e-05 4.426e-05 0.007669 0.619291 4.954327
GTGTTAGAC 1.626e-05 1.596e-05 0.004958 0.625175 4.376228
ACCTCTGTC 4.032e-05 3.957e-05 0.005543 0.729250 4.375499
GTCTAACAC 1.634e-05 1.596e-05 0.002582 0.752233 3.761164
AGGATGTGT 4.805e-05 4.725e-05 0.001627 0.795980 3.183920
TCTCCTCAA 5.775e-05 5.652e-05 0.006681 0.909561 2.728684
TCTCAGTCT 3.361e-05 3.263e-05 0.004097 0.945748 1.891496
GGTGTGTCT 2.855e-05 2.794e-05 0.005231 0.949554 0.949554
Table S2: Frequencies of ninemers and an eightmer in female vs. male samples
with the highest significance (training and holdout sets: two halves of Study
1). After the very strict Holm-Bonferroni corrections, no significant differences
were found.
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Figure S1: Empirical cumulative distribution function of the frequency of frag-
ment CTCGTGACA (solid: lean, dashed: obese)
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